Hydromorphone-OROS formulation

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.7, 2010-05, pp. : 1207-1214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of Hydromorphone, with Particular Reference to the OROS® Formulation, in the Elderly

By Lussier David Richarz Ute

Drugs & Aging, Vol. 27, Iss. 4, 2010-04 ,pp. : 327-335

Adis International

Access to resources Recommend Favorite

OROS hydromorphone of value for osteoarthritis pain

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 543, 2007-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Chronic conditions no longer a pain with OROS hydromorphone

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 504, 2006-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

OROS hydromorphone vs ER oxycodone: a close call in OA

Inpharma, Vol. 1, Iss. 1662, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

OROS hydromorphone vs ER oxycodone: a close call in OA

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 567, 2008-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite